Notice Number: NOT-CA-14-016
Key Dates
Release Date: January 2, 2014
PA-13-354
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in PA-13-354, entitled "Advancing the Science of Geriatric Palliative Care (R01)."
Part 1. Overview Information, the Components of Participating Organizations section has been revised as shown below to include the NCI:
Components of Participating Organizations
National Institute on Aging (NIA)
National Institute of Nursing Research (NINR)
National Center for Complementary and Alternative Medicine (NCCAM)
National Cancer Institute (NCI)
Part 1. Overview Information, the Catalog of Federal Domestic Assistance (CFDA) Number(s) has been revised as shown below to include the appropriate number for the NCI, which is 93.393:
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866, 93.213, 93.361, 93.393
In Part 2. Full Text of Announcement, Section I. Funding Opportunity Description, the following examples regarding the specific interests of the NCI in this funding opportunity are added:
Funding Opportunity Description
NCI’s focus includes studies that identify factors that contribute to tolerance of and adherence to cancer therapies and improved enrollment and retention in clinical trials. Examples of specific research topics include, but are not limited to:
- Analyzing and comparing biological, social, and psychological factors that place elderly patients at risk for poor outcomes (decreased survival, serious adverse events) during and following cancer treatment;
- Examining the trajectory of physical and functional abilities during cancer treatment;
- Developing and refining interventions that improve older patients’ tolerance of and adherence to cancer therapies; and
- Examining physician and patient factors that contribute to treatment decision-making, e.g., enrolling on clinical trials, dose reductions.
In Part 2. Section VII. Agency Contacts, the name and contact information for the NCI's representatives are added as follows:
Scientific/Research Contact(s)
Ann O'Mara, Ph.D., R.N., F.A.A.N.
National Cancer Institute (NCI)
Telephone: 240-276-7050
Email: [email protected]
Financial/Grants Management Contact(s)
Rosemary Ward
National Cancer Institute (NCI)
Telephone: 240-276-6320
Email: [email protected]
All other aspects of PA-13-354 remain the same.
Inquiries
Please direct all inquiries to:
Ann O'Mara, Ph.D., R.N., F.A.A.N.
National Cancer Institute
Telephone: 240-276-7050
Email: [email protected]
and Human Services (HHS)
